Global and Region Recombinant Hepatitis B Vaccine Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Recombinant Hepatitis B Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Hepatitis B Vaccinemarket, defines the market attractiveness level of Recombinant Hepatitis B Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Recombinant Hepatitis B Vaccine industry, describes the types of Recombinant Hepatitis B Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Hepatitis B Vaccine market and the development prospects and opportunities of Recombinant Hepatitis B Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Hepatitis B Vaccine market in Chapter 13.

    By Player:

    • Serum Institute of India

    • Beijing Tiantan Biological

    • GlaxoSmithKline Plc

    • Hualan Biological Engineering

    • Pfizer Inc

    • Johnson & Johnson

    • Sanofi Pasteur

    • Merck

    • China National Biotec Group

    • Emergent Biosolutions

    • Dalian Hissen Bio-pharm

    • CSL Limited

    • NCPC

    By Type:

    • 10mcg/ml

    • 10mcg/05ml

    By End-User:

    • Newborn

    • Primary School Students

    • Adult

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Recombinant Hepatitis B Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Recombinant Hepatitis B Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Recombinant Hepatitis B Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Recombinant Hepatitis B Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Recombinant Hepatitis B Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global Recombinant Hepatitis B Vaccine Consumption (2017-2022)

    • 7.2 United States Recombinant Hepatitis B Vaccine Consumption (2017-2022)

    • 7.3 Europe Recombinant Hepatitis B Vaccine Consumption (2017-2022)

    • 7.4 China Recombinant Hepatitis B Vaccine Consumption (2017-2022)

    • 7.5 Japan Recombinant Hepatitis B Vaccine Consumption (2017-2022)

    • 7.6 India Recombinant Hepatitis B Vaccine Consumption (2017-2022)

    • 7.7 South Korea Recombinant Hepatitis B Vaccine Consumption (2017-2022)

    8 Region and Country-wise Recombinant Hepatitis B Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)

    • 8.4 China Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)

    • 8.6 India Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)

    9 Global Recombinant Hepatitis B Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Hepatitis B Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 10mcg/ml Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 10mcg/05ml Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Hepatitis B Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Newborn Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Primary School Students Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Adult Consumption and Growth Rate (2017-2022)

    10 Global Recombinant Hepatitis B Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 10mcg/ml Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global 10mcg/05ml Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Newborn Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Primary School Students Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Adult Consumption Forecast and Growth Rate (2022-2028)

    11 Global Recombinant Hepatitis B Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Recombinant Hepatitis B Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Recombinant Hepatitis B Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Recombinant Hepatitis B Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Recombinant Hepatitis B Vaccine Market Competitive Analysis

    • 14.1 Serum Institute of India

      • 14.1.1 Serum Institute of India Company Details

      • 14.1.2 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Serum Institute of India Recombinant Hepatitis B Vaccine Product and Service

    • 14.2 Beijing Tiantan Biological

      • 14.2.1 Beijing Tiantan Biological Company Details

      • 14.2.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product and Service

    • 14.3 GlaxoSmithKline Plc

      • 14.3.1 GlaxoSmithKline Plc Company Details

      • 14.3.2 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product and Service

    • 14.4 Hualan Biological Engineering

      • 14.4.1 Hualan Biological Engineering Company Details

      • 14.4.2 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product and Service

    • 14.5 Pfizer Inc

      • 14.5.1 Pfizer Inc Company Details

      • 14.5.2 Pfizer Inc Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Inc Recombinant Hepatitis B Vaccine Product and Service

    • 14.6 Johnson & Johnson

      • 14.6.1 Johnson & Johnson Company Details

      • 14.6.2 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Product and Service

    • 14.7 Sanofi Pasteur

      • 14.7.1 Sanofi Pasteur Company Details

      • 14.7.2 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product and Service

    • 14.8 Merck

      • 14.8.1 Merck Company Details

      • 14.8.2 Merck Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Merck Recombinant Hepatitis B Vaccine Product and Service

    • 14.9 China National Biotec Group

      • 14.9.1 China National Biotec Group Company Details

      • 14.9.2 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 China National Biotec Group Recombinant Hepatitis B Vaccine Product and Service

    • 14.10 Emergent Biosolutions

      • 14.10.1 Emergent Biosolutions Company Details

      • 14.10.2 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product and Service

    • 14.11 Dalian Hissen Bio-pharm

      • 14.11.1 Dalian Hissen Bio-pharm Company Details

      • 14.11.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product and Service

    • 14.12 CSL Limited

      • 14.12.1 CSL Limited Company Details

      • 14.12.2 CSL Limited Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 CSL Limited Recombinant Hepatitis B Vaccine Product and Service

    • 14.13 NCPC

      • 14.13.1 NCPC Company Details

      • 14.13.2 NCPC Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 NCPC Recombinant Hepatitis B Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Recombinant Hepatitis B Vaccine

    • Figure Recombinant Hepatitis B Vaccine Picture

    • Table Global Recombinant Hepatitis B Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Hepatitis B Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Hepatitis B Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Recombinant Hepatitis B Vaccine Consumption by Country (2017-2022)

    • Figure United States Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Hepatitis B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 10mcg/ml Consumption and Growth Rate (2017-2022)

    • Figure Global 10mcg/05ml Consumption and Growth Rate (2017-2022)

    • Figure Global Newborn Consumption and Growth Rate (2017-2022)

    • Figure Global Primary School Students Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global 10mcg/ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 10mcg/05ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Newborn Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Primary School Students Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Recombinant Hepatitis B Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Recombinant Hepatitis B Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Serum Institute of India (Foundation Year, Company Profile and etc.)

    • Table Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Recombinant Hepatitis B Vaccine Product and Service

    • Table Beijing Tiantan Biological (Foundation Year, Company Profile and etc.)

    • Table Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product and Service

    • Table Hualan Biological Engineering (Foundation Year, Company Profile and etc.)

    • Table Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Recombinant Hepatitis B Vaccine Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Recombinant Hepatitis B Vaccine Product and Service

    • Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Recombinant Hepatitis B Vaccine Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Recombinant Hepatitis B Vaccine Product and Service

    • Table China National Biotec Group (Foundation Year, Company Profile and etc.)

    • Table China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table China National Biotec Group Recombinant Hepatitis B Vaccine Product and Service

    • Table Emergent Biosolutions (Foundation Year, Company Profile and etc.)

    • Table Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent Biosolutions Recombinant Hepatitis B Vaccine Product and Service

    • Table Dalian Hissen Bio-pharm (Foundation Year, Company Profile and etc.)

    • Table Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product and Service

    • Table CSL Limited (Foundation Year, Company Profile and etc.)

    • Table CSL Limited Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited Recombinant Hepatitis B Vaccine Product and Service

    • Table NCPC (Foundation Year, Company Profile and etc.)

    • Table NCPC Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table NCPC Recombinant Hepatitis B Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.